Newgenivf Group Cl A (NIVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -474 | 108 | 136 | N/A | N/A |
| Depreciation Amortization | 53 | 31 | 101 | N/A | N/A |
| Accounts receivable | -40 | 1 | 130 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,126 | 71 | 59 | N/A | N/A |
| Other Working Capital | -7,757 | -2,090 | 698 | N/A | N/A |
| Other Operating Activity | -1,172 | 112 | 588 | 0 | 0 |
| Operating Cash Flow | $-8,264 | $-1,766 | $1,711 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -53 | -70 | -95 | N/A | N/A |
| Investing Cash Flow | $-53 | $-70 | $-95 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 8,584 | N/A | 128 | N/A | N/A |
| Common Stock Issued | N/A | 192 | N/A | N/A | N/A |
| Other Financing Activity | 92 | 1,689 | -1,762 | 0 | 0 |
| Financing Cash Flow | $8,676 | $1,882 | $-1,634 | $N/A | $N/A |
| Exchange Rate Effect | 45 | -19 | 16 | N/A | N/A |
| Beginning Cash Position | 54 | 28 | 29 | N/A | N/A |
| End Cash Position | 458 | 54 | 28 | N/A | N/A |
| Net Cash Flow | $404 | $27 | $-1 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,264 | -1,766 | 1,711 | N/A | N/A |
| Capital Expenditure | -53 | -70 | -95 | N/A | N/A |
| Free Cash Flow | -8,317 | -1,836 | 1,616 | 0 | 0 |